跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,848 条关于
“PI3K/PTEN/AKT/mTOR”
全部
10,848
临床试验
7,570
药物
730
机构
324
资讯
2,224
去年
Dual Biopsy Approach Significantly Improves Survival in Advanced Cancer Patients
7个月前
Sensei Biotherapeutics Acquires Faeth Therapeutics for $200M to Advance PI3K/AKT/mTOR Pathway Inhibitor PIKTOR
9个月前
Rakovina Therapeutics Presents AI-Discovered CNS-Penetrant ATR/mTOR Dual Inhibitors at Neuro-Oncology Meeting
去年
Ryvu Therapeutics Discovers Synergistic mTOR-AKT Inhibitor Combination for Colorectal Cancer Treatment
去年
Truqap plus Abiraterone and ADT Improves rPFS in PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer
去年
Capivasertib Plus Abiraterone Extends Radiographic Progression-Free Survival in PTEN-Deficient mHSPC
去年
Faeth Therapeutics Advances Novel Three-Pronged Approach for Metabolism-Driven Cancers with Promising Preclinical Results
11个月前
Frontier Medicines Unveils FMC-242, Novel PI3Kα/RAS Inhibitor Targeting Cancer's Most Common Genetic Drivers
上个月
Non-Tyrosine Kinase Inhibitors Market to Reach USD 18.7 Billion by 2036, Driven by Biomarker-Linked Oncology Approvals
9个月前
Tumor-Associated Macrophages Drive Gastric Cancer Progression Through Immune Evasion and Therapeutic Resistance
第 1 页,共 223 页
上一页
下一页